Ethyl Acetate

Ethyl Acetate

SCHEMBL329089

CCOC(C)=O.c1ccccc1.c1ccccc1.c1ccccc1.c1ccccc1.c1ccccc1.c1ccccc1.c1ccccc1.c1ccccc1.c1ccccc1

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.82
LMNA P02545 1/20 0.82
HSD17B10 Q99714 1/20 0.82
TSHR P16473 2/20 0.50
GAA P10253 2/20 0.46
ALOX15 P16050 1/20 0.46
MGAM O43451 1/20 0.46
SI P14410 1/20 0.46
MGAM2 Q2M2H8 1/20 0.46
SOAT1 P35610 1/20 0.46
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
HCAR2 Q8TDS4 1/20 0.42
PIN1 Q13526 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL11511384 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL10991977 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL508537 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL8935437 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL6543826 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL9665914 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL10771774 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL9495 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL9507364 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL7455458 1.00 ALDH1A1 (0.82) ALDH1A1LMNAHSD17B10TSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2407447-B1 METHOD FOR PRODUCING OPTICALLY ACTIVE 2-HYDROXY ESTER TOKYO UNIV OF SCIENCE EDUCATIONAL FOUNDATION ADMINISTRATIVE ORGANIZATION (JP) 2018-04-18 EP disclosed
EP-1031573-B2 USE OF A BENZOYLPYRAZOLE COMPOUND AS HERBICIDE NIPPON SODA CO (JP) 2015-05-27 EP disclosed
US-8552215-B2 Method for producing optically active 2-hydroxy ester and novel intermediate compound TOKYO UNIVERSITY OF SCIENCE EDUCATIONAL FOUNDATION ADMINISTRATIVE ORGANIZATION (JP) 2013-10-08 US disclosed
EP-2407447-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE 2-HYDROXY ESTER AND NOVEL INTERMEDIATE COMPOUND Tokyo University Of Science Educational Foundation Administrative Organization (JP) 2012-01-18 EP disclosed
US-20110319650-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE 2-HYDROXY ESTER AND NOVEL INTERMEDIATE COMPOUND TOKYO UNIVERSITY OF SCIENCE EDUCATIONAL FOUNDATION ADMINISTRATIVE ORGANIZATION (JP) 2011-12-29 US disclosed
US-7910762-B2 mixing a pentavalent niobium compound and a tetraol having an optically active binapthol; catalysts for the following asymmetric reactions: Mannich, epoxide ring opening, allylation, cyanation, and alkylation; reacting silicon enolate with imine to form beta-aminocarbonyl compound JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2011-03-22 US disclosed
EP-1031573-B1 NOVEL BENZOYLPYRAZOLE COMPOUNDS, INTERMEDIATES, AND HERBICIDES NIPPON SODA CO (JP) 2008-03-26 EP disclosed
US-20050032858-A1 Novel heterocyclic compound and anti-inflamatory agent NIPPON SODA CO., LTD. (JP) 2005-02-10 US disclosed
WO-2005000242-A2 PROCESS FOR MAKING POLYMORPHIC FORM A OF 4-[6-ACETYL-3-[3-(4-ACETYL-3-HYDROXY-2-PROPYLPHENYLTHIO)PROPOXY]BUTYRIC ACID MEDICINOVA, INC. (US) 2005-01-06 WO disclosed
EP-1435353-A1 NOVEL HETEROCYCLIC COMPOUND AND ANTI-INFLAMMATORY AGENT NIPPON SODA CO., LTD. (JP) 2004-07-07 EP disclosed
EP-0373226-B1 Carbamoyl-2-pyrrolidinone compounds TAIHO PHARMACEUTICAL CO LTD (JP) 1994-06-15 EP disclosed
US-5229402-A Improving cerebral function TAIHO PHARMACEUTICAL COMPANY, LTD. (JP) 1993-07-20 US disclosed
EP-0373226-A1 Carbamoyl-2-pyrrolidinone compounds TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 1990-06-20 EP disclosed
US-4736034-A CARDIOTONIC AGENTS ROUSSEL UCLAF (FR) 1988-04-05 US disclosed
EP-0258055-A2 A new pesticidal composition NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1988-03-02 EP disclosed
EP-0236074-A1 2Beta-substituted thiomethylpenicillin derivatives and their preparation and use TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) 1987-09-09 EP disclosed
US-4661482-A HYPOTENSIVE AGENTS ROUSSEL UCLAF (FR) 1987-04-28 US disclosed
EP-0115969-A1 Penem compounds, their preparation , formulations containing the same and their use in combating bacteria SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) 1984-08-15 EP disclosed
US-4369174-A SKIN WHITENERS SANSHO PHARMACEUTICAL CO., LTD. (JP) 1983-01-18 US disclosed
US-4278656-A WHITENING HUMAN SKIN SANSHO PHARMACEUTICAL CO., LTD. (JP) 1981-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032858-A1 Novel heterocyclic compound and anti-inflamatory agent TLR5, IRF3, IL4 ALDH1A1 2547/4885LMNA 3465/4885HSD17B10 2929/4885
US-20110319650-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE 2-HYDROXY ESTER AND NOVEL INTERMEDIATE COMPOUND CA7, HAO2, HACL2 ALDH1A1 239/4885LMNA 3908/4885HSD17B10 86/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.